CLNNW: the cash flow

Cash Flow Overview

Change in Cash

$640K

Free Cash flow

-$4,003K

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2025-09-30

2025-06-30

Net loss

-8,777

-8,170

Depreciation

365

770

Non-cash lease expense

148

270

Issuance of common stock as payment of outstanding indebtedness

-8

Change in fair value of common stock warrant liabilities

1,728

-1,995

Change in fair value of derivative liabilities

-797

708

Change in fair value of clene nanomedicine contingent earn-out liability

Change in fair value of initial stockholders contingent earn-out liability

Stock-based compensation expense

1,703

3,314

Accretion of debt discount

252

488

Non-cash interest income on marketable securities

Non-cash interest expense on notes payable

-216

-24

Accounts receivable

-64

Inventory

-18

Prepaid expenses and other current assets

751

Accounts payable

541

-412

Accrued liabilities

-465

-2,307

Operating lease obligations

-452

-339

Net cash used in operating activities

-3,992

-9,755

Purchases of marketable securities

Proceeds from maturities of marketable securities

Purchases of property and equipment

Net cash provided by (used in) investing activities

-11

Proceeds from exercise of stock options

Proceeds from issuance of common stock, net of offering costs

3,266

4,977

Proceeds from share subscriptions payable

Proceeds from the issuance of debt and derivative liabilities

1,500

Payments of notes payable

124

171

Payments of finance lease obligations

Net cash provided by (used in) financing activities

4,642

4,806

Effect of foreign exchange rate changes on cash and restricted cash

Net decrease in cash, cash equivalents and restricted cash

640

-4,870

Cash and cash equivalents at beginning of period

12,213

Cash and cash equivalents at end of period

7,983

Time Plot

Show the time plot by selecting a row from the table.